Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534.SZ)
- Previous Close
7.90 - Open
7.47 - Bid 7.95 x --
- Ask 7.96 x --
- Day's Range
7.78 - 8.02 - 52 Week Range
6.30 - 12.36 - Volume
5,044,700 - Avg. Volume
10,404,218 - Market Cap (intraday)
2.412B - Beta (5Y Monthly) --
- PE Ratio (TTM)
39.75 - EPS (TTM)
0.20 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date May 27, 2020
- 1y Target Est
--
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD researches, develops, produces, and sells Chinese patent medicines, health food, and APIs in China and internationally. The company offers Xuanfei Zhicough mixture, Yuanhu Zhitong dropping pills, Qiwei Wenyang capsules, Maxing cough capsule, and Astragalus Angelica capsules. Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD was founded in 2002 and is based in Lanzhou, China.
www.lsrfzy.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Related News
Performance Overview: 300534.SZ
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 300534.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 300534.SZ
Valuation Measures
Market Cap
2.40B
Enterprise Value
2.25B
Trailing P/E
38.88
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.22
Price/Book (mrq)
3.78
Enterprise Value/Revenue
2.09
Enterprise Value/EBITDA
17.21
Financial Highlights
Profitability and Income Statement
Profit Margin
5.71%
Return on Assets (ttm)
5.63%
Return on Equity (ttm)
11.37%
Revenue (ttm)
1.08B
Net Income Avi to Common (ttm)
61.65M
Diluted EPS (ttm)
0.20
Balance Sheet and Cash Flow
Total Cash (mrq)
288.95M
Total Debt/Equity (mrq)
20.32%
Levered Free Cash Flow (ttm)
240.14M
Company Insights: 300534.SZ
300534.SZ does not have Company Insights